Integrating Physician Opinions Into DLBCL Treatment SelectionByPatrick Connor Johnson, MDFebruary 4th 2022Patrick Connor Johnson, MD, discusses what physicians take into consideration when integrating third-line treatment options in diffuse large B-cell lymphoma